Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAbbVie Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 13 | $2.32 | $2.53 | $2.38 |
| Q2 2025 | 14 | $2.74 | $3.10 | $2.88 |
| Q3 2025 | 13 | $1.67 | $1.88 | $1.77 |
| Q4 2025 | 13 | $3.28 | $3.52 | $3.35 |
| Q1 2026 | 7 | $2.91 | $3.14 | $3.05 |
| Q2 2026 | 4 | $3.57 | $3.79 | $3.64 |
| Q3 2026 | 3 | $3.62 | $3.84 | $3.68 |
| Q4 2026 | 2 | $3.82 | $4.05 | $3.89 |
| Q1 2027 | 2 | $3.41 | $3.62 | $3.47 |
| Q2 2027 | 2 | $4.31 | $4.58 | $4.39 |
| Q3 2027 | 2 | $3.69 | $3.92 | $3.76 |
| Q4 2027 | 2 | $4.28 | $4.54 | $4.36 |
AbbVie Inc. Earnings Date And Information
AbbVie Inc. last posted its earnings results on Friday, October 31st, 2025. The company reported $1.86 earnings per share for the quarter, topping analysts' consensus estimates of $1.77 by $0.09. The company had revenue of 15.78 B for the quarter and had revenue of 56.33 B for the year. AbbVie Inc. has generated $2 earnings per share over the last year ($2.39 diluted earnings per share) and currently has a price-to-earnings ratio of 167.34. AbbVie Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, October 31st, 2025 based on prior year's report dates.
AbbVie Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/04/2025 | Q3 2025 | N/A | $0.10 | N/A | $15.59 B | $15.78 B |
| 08/04/2025 | Q2 2025 | N/A | $0.53 | N/A | $15.03 B | $15.42 B |
| 05/09/2025 | Q1 2025 | N/A | $0.72 | N/A | N/A | $13.34 B |
| 02/14/2025 | Q4 2024 | N/A | -$0.02 | N/A | N/A | $15.10 B |
| 11/04/2024 | Q3 2024 | N/A | $0.88 | N/A | $14.28 B | $14.46 B |
| 08/07/2024 | Q2 2024 | N/A | $0.77 | N/A | $14.02 B | $14.46 B |
| 05/03/2024 | Q1 2024 | N/A | $0.77 | N/A | N/A | $12.31 B |
| 02/20/2024 | Q4 2023 | N/A | $0.46 | N/A | N/A | $14.30 B |
| 11/06/2023 | Q3 2023 | N/A | $1.00 | N/A | $13.72 B | $13.93 B |
| 08/07/2023 | Q2 2023 | N/A | $1.14 | N/A | $13.54 B | $13.87 B |
| 05/05/2023 | Q1 2023 | N/A | $0.13 | N/A | $12.17 B | $12.23 B |
| 02/17/2023 | Q4 2022 | N/A | $1.40 | N/A | $15.33 B | $15.12 B |
| 11/04/2022 | Q3 2022 | N/A | $2.23 | N/A | $14.96 B | $14.81 B |
| 08/04/2022 | Q2 2022 | N/A | $0.52 | N/A | $14.66 B | $14.58 B |
| 05/06/2022 | Q1 2022 | N/A | $2.54 | N/A | $13.61 B | $13.54 B |
| 02/18/2022 | Q4 2021 | N/A | $2.29 | N/A | $14.95 B | $14.89 B |
| 11/02/2021 | Q3 2021 | N/A | $1.78 | N/A | $14.30 B | $14.34 B |
| 08/02/2021 | Q2 2021 | N/A | $0.42 | N/A | $13.63 B | $13.96 B |
| 05/07/2021 | Q1 2021 | N/A | $2.00 | N/A | $12.77 B | $13.01 B |
| 02/19/2021 | Q4 2020 | N/A | $0.01 | N/A | $13.70 B | $13.86 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
AbbVie Inc. Earnings: FAQ's
AbbVie Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, October 31st, 2025 based offlast year's report dates.
In the previous quarter, AbbVie Inc. (:ABBV) reported $1.86 earnings per share (EPS) to beat the analysts' consensus estimate of $1.77 by $0.09.
The conference call for AbbVie Inc.'s latest earnings report can be listened to online.
The conference call transcript for AbbVie Inc.'s latest earnings report can be read online.
AbbVie Inc. (:ABBV) has a recorded annual revenue of $56.33 B.
AbbVie Inc. (:ABBV) has a recorded net income of $4.28 B.AbbVie Inc. has generated $2.4 earnings per share over the last four quarters.
AbbVie Inc. (:ABBV) has a price-to-earnings ratio of 167.34 and price/earnings-to-growth ratio is -4.53.